August 24, 2022
InMed Announces Share Consolidation to Meet Nasdaq Listing Criteria
VANCOUVER, British Columbia, Aug. 23, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader…
Pharmaceuticals, Biotechnology and Life Sciences
VANCOUVER, British Columbia, Aug. 23, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader…
MISSISSAUGA, Ontario, Aug. 23, 2022 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce…
MISSISSAUGA, Ontario, Aug. 23, 2022 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for…
MALVERN, Pa., Aug. 23, 2022 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical technology company focused on providing…
Saint-Herblain (France), August 23, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, confirms today that…
Company announcement no. 10 – 2223 August 2022 Transactions in connection with share buy-back program On 12 August 2022 NTG…
World first study utilizing Somalogic SomaScan® assay# to assess up to 7,000 plasma proteins in Long COVID-19 patients has elucidated…
COPENHAGEN, Denmark, August 23, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that Elizabeth McKee Anderson has decided to…
First clinical data on safety and activity of NTLA-2002, Intellia’s second systemically administered in vivo CRISPR candidate CAMBRIDGE, Mass., Aug.…
New York, NY, and Tel Aviv, ISRAEL, Aug. 23, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive…